![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 4, 1529-1544, April 2003

and
*Department of Medical Parasitology and Infection Biology,
Swiss Tropical Institute, Basel CH 4002, Switzerland; and
Nuffield Department of Pathology, University of
Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
After invasion of erythrocytes, the human malaria parasite Plasmodium falciparum resides within a parasitophorous vacuole and develops from morphologically and metabolically distinct ring to trophozoite stages. During these developmental phases, major structural changes occur within the erythrocyte, but neither the molecular events governing this development nor the molecular composition of the parasitophorous vacuole membrane (PVM) is well known. Herein, we describe a new family of highly cationic proteins from P. falciparum termed early transcribed membrane proteins (ETRAMPs). Thirteen members were identified sharing a conserved structure, of which six were found only during ring stages as judged from Northern and Western analysis. Other members showed different stage-specific expression patterns. Furthermore, ETRAMPs were associated with the membrane fractions in Western blots, and colocalization and selective permeabilization studies demonstrated that ETRAMPs were located in the PVM. This was confirmed by immunoelectron microscopy where the PVM and tubovesicular extensions of the PVM were labeled. Early expressed ETRAMPs clearly defined separate PVM domains compared with the negatively charged integral PVM protein EXP-1, suggesting functionally different domains in the PVM with an oppositely charged surface coat. We also show that the dynamic change of ETRAMP composition in the PVM coincides with the morphological changes during development. The P. falciparum PVM is an important structure for parasite survival, and its analysis might provide better understanding of the requirements of intracellular parasites.
| |
INTRODUCTION |
|---|
|
|
|---|
Plasmodium falciparum, the causative agent of the most dangerous form of human malaria, provokes >200 million clinical attacks and kills 1-3 million people each year. A vaccine against malaria is still not available and resistance to drugs is widespread. Improvement of this situation is unlikely to occur without an increased understanding of many aspects of P. falciparum biology that could reveal new intervention targets.
The symptoms of malaria are caused by the asexual development of the
parasite within red blood cells (RBCs). Encompassed in a
parasitophorous vacuolar membrane (PVM), the parasites develop from
ring stages (0-22 h postinvasion [hpi]) to trophozoites (22-36 hpi)
and finally to schizonts (36-48 hpi). Rupture of schizonts releases up
to 24 merozoites into the bloodstream, which initiate a new round of
schizogony. Human erythrocytes are highly specialized cells devoid of
internal organelles and a functional protein-trafficking system. This
metabolically inert cell allows the parasite to hide from the immune
system. As a trade-off, the parasite needs to refurbish the host cell
to import nutrients, dispose of waste products, and export proteins
across its plasma membrane (PPM), the surrounding PVM, and the
erythrocyte cytosol and plasma membrane. Parasite-induced modifications
in the host cell are believed to mediate these tasks. A tubovesicular
network extends from the PVM into the cytoplasm of trophozoite-infected
RBCs (Elmendorf and Haldar, 1993
, 1994
). In addition, flattened
vesicular structures (Maurer's clefts) normally running parallel to
and just beneath the red cell membrane occur in the host cell cytosol
of late ring stage-infected erythrocytes (Langreth et al.,
1978
). Maurer's clefts were proposed to be involved in transport of
parasite proteins to the RBC plasma membrane (Barnwell, 1990
;
Hinterberg et al., 1994
) and are associated with P. falciparum homologs of proteins involved in vesicle transport
(Albano et al., 1999a
; Adisa et al., 2001
).
Recently, they also have been shown to be involved in transport and
possibly assembly of proteins forming knobs (Wickham et al.,
2001
). New permeation pathways occur at >15 hpi in the host cell
membrane (Staines et al., 2001
), and several parasite proteins become associated with the RBC cytoskeleton (reviewed in Cooke
et al., 2001
). Appearance of these modifications at the late
ring to early trophozoite stage coincides with onset of rapid parasite
growth and sequestration in postcapillary venules in vivo. To date,
little is known about the molecular events taking place in the
preceding ring stage. Compared with later stage parasites, ring stages
are characterized by low metabolic and biosynthetic activity (Zolg
et al., 1984
; de Rojas and Wasserman, 1985
; ter Kuile
et al., 1993
) and little change in size and morphology. However, it is unlikely that the parasite lies dormant during half of
its asexual development in RBCs, and we assumed that this "lag"-phase serves the parasite to induce the elaborate host cell modifications apparent in later stages. This initial host cell refurbishment is necessary for growth and survival and must include a
protein-trafficking system to deliver the required components beyond
the parasite's boundaries into different locations of the host cell.
Apart from the intriguing cell biological aspects, this unique
situation most probably demands unusual processes essential for
parasite survival. These might be sufficiently different from host
processes to present new targets for interventions that would leave the
host unaffected.
We have used suppression subtractive hybridization to clone genes
exclusively transcribed during the P. falciparum ring stage (Spielmann and Beck, 2000
). In contrast to genes originating from a
trophozoite-specific library, few of the identified ring-specific genes
showed homologies to known genes of other organisms, which is in
accordance with the unique nature of the molecular events in early
stages. One of these genes has previously been shown to code for a
protein located in Maurer's clefts and was proposed to bind the
erythrocyte scaffold (Blisnick et al., 2000
). Among the
other ring stage-specific genes, we identified three members of a new
gene family coding for highly charged putative membrane proteins we
referred to as early transcribed membrane proteins (etramp)
(Spielmann and Beck, 2000
). Herein, we report on the complete
identification of 13 different etramps. Expression of six
ETRAMPs was highly ring stage specific, whereas the others showed a
different developmental regulation. ETRAMPs localized to the PVM,
defining domains distinct to the distribution of the PVM protein EXP-1.
Furthermore, we show that the composition of individual ETRAMP members
in the PVM changes in a developmentally regulated manner. This change
occurs at the transition from ring stage to trophozoite and correlates
with appearance of parasite proteins in the RBC cytoplasm and onset of
rapid parasite growth. Our findings provide new insights about the
Plasmodium PVM and cell biology of intracellular pathogens
in general. We suggest that ETRAMPs play an important role in parasite
survival and might represent new targets for drug-mediated interventions.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Identification of etramps and Sequence Analysis
The RsaI cDNA fragments of three different
etramps (clones R4b, R1.10, and R20; Spielmann and Beck,
2000
) were used to deduce the complete open reading frames (ORFs) from
the P. falciparum genome project with the program BlastN
(Altschul et al., 1990
; http://www.tigr.org;
http://www.sanger.ac.uk/Projects/P_falciparum/; http://sequence-www.stanford.edu/group/malaria/). The predicted amino
acid (aa) sequences were used to identify additional related sequences
in the P. falciparum genome by using tBLASTN on the same Web
sites and on the National Center for Biotechnology Information custom
BLAST server
(http://www.ncbi.nlm.gov/Malaria/plasmodiumblcus.html). Chromosomal
organization of etramps was determined using PlasmoDB (http://plasmodb.org/, release 3.2, 30.11.01; Bahl et al.
2002
). We thank the scientists and funding agencies comprising the
international Malaria Genome Project for making sequence data from the
genome of P. falciparum (3D7) public before publication of
the completed sequence. The Sanger Center (Cambridge, United
Kingdom) provided sequence for chromosomes 1, 3-9, and 13, with
financial support from the Wellcome Trust. A consortium composed of The
Institute for Genome Research, along with the Naval Medical Research
Center (Baltimore, MD), sequenced chromosomes 2, 10, 11, and 14, with support from National Institute of Allergy and Infectious
Diseases/National Institutes of Health, the Burroughs Wellcome Fund,
and the Department of Defense. The Stanford Genome Technology Center
(Palo Alto, CA) sequenced chromosome 12, with support from the
Burroughs Wellcome Fund. The Plasmodium Genome Database is a
collaborative effort of investigators at the University of Pennsylvania
(Philadelphia, PA) and Monash University (Melbourne, Australia),
supported by the Burroughs Wellcome Fund.
The following programs available at http://www.expasy.ch were used for
etramp sequence analysis: compute pI/MW tool (Bjellqvist et al., 1993
), SignalP version 2.0 (Nielsen et
al., 1997
), TMHMM (Krogh et al., 2001
; Moller et
al., 2001
), ClustalX at EBI European Bioinformatics
Institute (Oxford, United Kingdom) (Thompson et al., 1994
),
Coils (Lupas et al., 1991
), Paircoil (Berger et
al., 1995
), and PESTfind (Rogers et al., 1986
). PC gene
version 6.7 was used to plot a dendrogram.
Parasite Culture
P. falciparum strain 3D7 was cultured as described
previously (Trager and Jensen, 1978
) by using 0.5% AlbuMAX
(Invitrogen, Groningen, Switzerland) as a substitute of human serum
(Dorn et al., 1995
). Parasites were synchronized with 5%
sorbitol (Lambros and Vanderberg, 1979
). One cycle before harvest,
already synchronously growing parasites were synchronized with two
sorbitol treatments 12 h apart to obtain highly synchronous parasites.
Northern Analysis
Templates to prepare specific probes were generated by
polymerase chain reaction (PCR) on 3D7 DNA with primers listed in Table 1, except for etrampBLOB.1 and
11.2. For etrampBLOB.1, clone R10 (Spielmann and
Beck, 2000
) was used as a template. For etramp11.2, a clone
obtained from a pool of four different ETRAMP sequences generated with
degenerate primers (5'-ATGAAARTYWCAARGATYTYRTWTTTY-3' and
5'-GCWAMASCNGARGCWAYRGMAGWR-3') was used as a template. PCR products were purified using NucleoSpin columns (Macherey-Nagel, Oesingen, Switzerland) and labeled using
[
-32P]dCTP and the HighPrime system (Roche
Diagnostics, Rotkreuz, Switzerland).
|
Northern blotting was done as described previously (Spielmann and Beck,
2000
). Total RNA was prepared using TRIzol reagent (Invitrogen) and
separated on 1.4% agarose gels containing 5 mM guanidinium
isothiocyanate (Goda and Minton, 1995
; Kyes et al., 2000
).
Equal loading (~5 µg/lane) and quality of RNA were checked visually. The gel was soaked in 10× SSC for 30 min and transferred to
Hybond XL membranes (Amersham Biosciences, Dübendorf,
Switzerland) for 3 h with 10× SSC containing 10 mM NaOH with a
vacuum blotter (Appligene Oncor, Basel, Switzerland). Hybridization was
carried out at 42°C in UltraHyb (Ambion, Lugano, Switzerland)
overnight. Filters were washed with high stringency (0.1×
SSC/0.1%SDS) at 50°C. Autoradiography was done at
70°C by using
a Transcreen HE enhancer and MS films (Eastman Kodak, Rochester, NY).
Expression of Recombinant ETRAMP-GST Fusion Proteins in Escherichia coli and Immunization
The sequences coding for the C terminus of
etramp2 (nucleotide [nt] 211-318), etramp4 (nt
226-426), etramp10.1 (nt 211-321), etramp10.2
(nt 232-1065), and etramp13 (nt 250-555, partial C terminus
only) were PCR amplified using primers listed in Table 1 and cloned
into the SmaI site 3' of the glutathione
S-transferase (GST) in pGEX-6P-2 (Amersham Biosciences) by
cycle restriction ligation (Push et al., 1997
). Constructs
were confirmed by sequencing. GST fusion proteins were expressed in
E. coli BL21 cells and purified using glutathione-Sepharose
(Amersham Biosciences).
Mice were immunized with a total of three injections 10-14 d apart, each containing 10 µg of recombinant protein in RIBI adjuvant (Corixa, Seattle, WA).
Preparation of Parasite Protein Extracts
For total parasite extracts, parasites were released from RBCs by lysis with 0.03% saponin for 20 min on ice, washed in phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4), and resuspended in Laemmli sample buffer.
Triton X-114 phase separation (Bordier, 1981
) was performed according
to Smythe et al. (1988)
with modifications. Ten milliliters of parasite culture (10% parasitemia) was saponin treated to release parasites from RBCs, washed in human tonicity phosphate-buffered saline
(HTPBS; 137 mM NaCl, 2.7 mM KCl, 8.1 mM sodium phosphate, pH 7.2),
resuspended in 0.7 ml of 1× HTPBS containing 0.5% Triton X-114 and 1 mM phenylmethylsulfonyl fluoride, and stored at
20°C until use.
After thawing, the extract was kept on ice for 30 min with intermittent
mixing. Twenty microliters was removed and Laemmli sample buffer was
added. The remaining extract was spun at 15,000 × g
for 20 min to pellet insoluble material. The insoluble fraction was
washed three times in HTPBS containing 0.5% Triton X-114 and resuspended in Laemmli sample buffer. The supernatant, containing the
detergent-soluble proteins, was layered over a 0.5-ml ice-cold sucrose
cushion (6% sucrose, 0.06% Triton X-114), incubated at 37°C for 5 min, and centrifuged at 500 × g for 5 min at room
temperature. The resulting three phases were treated as follows: 1) the
detergent-depleted upper layer was collected, Triton X-114 added to
0.5%, and the depletion step repeated; 2) the sucrose cushion was
discarded; and 3) the detergent pellet, containing the membrane
proteins, was resuspended in 0.5 ml of HTPBS, the purification over a
sucrose cushion was repeated, and the pellet resuspended in 0.5 ml of HTPBS. Both the final detergent-depleted fraction (1) and the final
detergent fraction (3) were precipitated with trichloroacetic acid and
analyzed by SDS-PAGE (Laemmli, 1970
).
Saponin-lysed and trypsinized infected red blood cells (IRBCs) were
obtained as described by Ansorge et al. (1997)
. Five
milliliters of saponin-lysed parasite culture (5-10% parasitemia) was
washed and resuspended in 500 µl of RPMI 1640 medium either with or
without 1 mg/ml trypsin and incubated at 37°C for 30 min. Cells were
spun at 2000 × g and resuspended in PBS containing 2 mg/ml trypsin inhibitor and incubated for 15 min at 37°C. Cells were
washed, resuspended in 10 mM Tris-HCl pH 8.0, and resolved by SDS-PAGE.
Western Analysis
Western analysis was carried out according to standard
procedures (Ausubel et al., 1989
) with the following
modifications. Methanol was omitted from all buffers because of the
sensitivity of the epitope. Proteins were transferred to a porablot
0.2-µm polyvinylidene difluoride membrane (Macherey-Nagel, Oesingen, Switzerland) in 10 mM CAPS pH 10.8 for 3 h by using a
Trans-Blot semidry electroblotter (Bio-Rad, Reinach, Switzerland).
Blots were washed with 1× PBS, and antibody incubation and blocking were done in 1× PBS containing 1% bovine serum albumin (BSA). Dilutions of mouse antisera (containing 50% glycerol) were as follows:
ETRAMP2, 1/300; ETRAMP10.1, 1/350; ETRAMP4, 1/400; ETRAMP10.2, 1/250;
monoclonal anti-GAPDH antibody, 1/120; and anti-rabbit EXP-1 serum,
1/400. The EXP-1 serum (raised against the C terminus of EXP-1) was a
kind gift of Dr. Lingelbach (Phillips-Universität, Marburg,
Germany). The monoclonal antibody against GAPDH (purified B-cell
supernatant) was a kind gift of Dr. Daubenberger (Swiss Tropical
Institute, Basel, Switzerland). Alkaline phosphatase-conjugated anti-mouse IgG (Sigma, Buchs, Switzerland) diluted 1/2000 was used as
secondary antibody.
Indirect Immunofluorescence Assay
Ten-well, 8-mm slides (Bio-Microtech, Bolton, ON, Canada) were coated for 30 min with 20 µl of concanavalin A (0.5 mg/ml in distilled H2O; Sigma), and IRBCs in PBS were added to the wells for 20 min. Unbound IRBCs were washed off. For selective permeabilization, 0.01% saponin or 0.1% Triton X-100 was added to the wells for 30 min at 4°C either in PBS (no fixation), in PBS/0.1% formaldehyde (mild fixation), or in PBS/0.5% formaldehyde (increased fixation). For streptolysin O (SLO; Sigma) treatment 20 U of SLO was added in PBS and incubated for 15 min, and then wells were washed three times and fixed if required. Control wells were treated with PBS, 0.1 or 0.5% formaldehyde in PBS only. For complete fixation, bound IRBCs were air-dried and subsequently fixed with 1% formaldehyde or 100% acetone for 15 min at room temperature, followed by three washes with PBS. Wells were blocked for 15 min in PBS/1% BSA, and primary antibody was added in blocking solution for 1 h. After five washes with PBS/1% BSA, second antibody was added in PBS/1% BSA for 1 h and washed again five times. Mouse sera containing 50% glycerol were used at 1/120 (anti-ETRAMP2), 1/150 (anti-ETRAMP10.1), 1/200 (anti-ETRAMP4), and 1/75 (anti-ETRAMP10.2). Rabbit sera were kindly provided by Dr. Lingelbach and used at 1/400 (anti-aldolase and anti-SERP) and 1/200 (anti-EXP-1C). Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (0.5 mg/ml; KPL, Gaithersburg, MD) was diluted 1/300, Cy3-conjugated goat anti-rabbit IgG (Jackson Immunoresearch Laboratories, West Groove, PA) 1/500, and Texas Red-conjugated goat anti-rabbit IgG (Southern Biotechnology Associates, Birmingham, AL) 1/400. Parasite nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) (5 µg/ml) added to the secondary antibody solution. Slides were analyzed by light microscopy or with a TCS SP confocal laser scanning microscope (Leica, Wetzlar, Germany).
Secondary antibody alone and uninfected RBCs were used as negative controls and were always unlabeled. There was also no signal with preimmune sera or with a serum raised against GST alone. Competition immunofluorescence assays (IFAs) were done as described above, except that 15 min before addition to a slide, primary antisera were diluted in blocking solution containing 1 mg/ml recombinant ETRAMP-GST fusion protein or GST alone.
Immunoelectron Microscopy
A preembedding protocol was used. Unsynchronized infected red blood cells were saponin-permeablized and then resuspended in the primary antibody (either anti-ETRAMP2 or anti-ETRAMP4 serum containing 50% glycerol) with a dilution of 1:40 in PBS for 1 h. The samples were then washed in buffer and resuspended in anti-mouse Ig conjugated to 5-nm gold with a dilution of 1:50 in PBS for 1 h. After washing, the samples were fixed in 2% glutaraldehyde and processed for electron microscopy by routine techniques. This involved postfixation in osmium tetroxide, dehydration in ethanol, treatment with propylene oxide, and embedding in Spurrs's epoxy resin. Thin sections were stained with uranyl acetate and lead citrate before examination in a 1200EX electron microscope (JOEL, Tokyo, Japan).
| |
RESULTS |
|---|
|
|
|---|
Identification and General Structure of etramps
Using three previously identified etramp sequences
(accessions AJ290924, AJ290926, and AJ290927; Spielmann and Beck, 2000
), we identified 10 additional sequences from the P. falciparum genome project with similarities to the original
etramps. Thus, we have identified a new gene family
comprising 13 related open reading frames of 91-355 amino acids,
hereafter referred to as "etramp " with the extension
giving the chromosome number they were found on (Table 1). Part of
etrampBLOB1 has previously been published as antigen22
(Horii et al., 1988
), and part of etramp13 has
been published as OrfP (Sallicandro et al., 2000
).
All etramps were predicted to be encoded by a single exon.
All members of the ETRAMP family share the same general structure (Figure 1B) with a predicted N-terminal
signal peptide, a short (~20 aa) cationic domain followed by a
predicted transmembrane domain (TM), and a highly charged C-terminal
domain of variable length (22-280 aa). Amino acid sequence alignment
of the six most similar ETRAMPs is shown in Figure 1A. The large number
of positively charged residues in etramp coding regions
results in a calculated pI of 9-10.4, except for ETRAMPBLOB.1, which
is rich in negative residues with a calculated pI of 5.3. This sequence
is unique also in an ~50 aa insertion between the signal peptide and
the transmembrane segment, consisting mainly of serines and prolines but otherwise seeming to resemble ETRAMPs. Several ETRAMPs contained regions of 20-30 aa in length, flanking the TM N and/or C terminally, that were predicted to have a tendency to form coiled coils.
|
To test whether ETRAMP features were not just common features of many
P. falciparum integral membrane proteins, we compared all
ETRAMPs with 21 predicted integral membrane proteins containing a
single TM domain that were randomly selected from published sequences
of chromosomes 2 and 3 (Gardner et al., 1998
; Bowman et al., 1999
). Apart from some similarities in the signal
peptides and transmembrane domains, all selected sequences were clearly distinct from ETRAMPs (our unpublished data).
Analysis of the chromosomal location of etramps by using PlasmoDB revealed that the six most closely related etramps are located within 20-60 kb to the subtelomeric rifins, except etramp12, which lies within 10 kb from the chromosome internal var cluster. etramps11.1 and 11.2 are linked tail to tail within 3.2 kb, suggesting that they may have evolved from a sequence duplication event.
Limited sequencing of etramps from different isolates gave no evidence of sequence polymorphism (our unpublished data). None of the etramp coding regions showed significant sequence homologies to known proteins of other organisms in a BLAST search against a nonredundant protein database. But searches using National Center for Biotechnology Information custom BLAST and PlasmoDB revealed homologous sequences sharing the same overall structure in P. vivax, P. berghei, and P. yoelii. A preliminary analysis showed that at least nine of the P. yoelii etramps homologs code for proteins that share much higher homology to each other than to P. falciparum ETRAMPs, and are more conserved than the six most closely related P. falciparum ETRAMPs (our unpublished data).
Stage-specific Transcription of etramps
To test whether all etramps were ring stage-specifically transcribed and to analyze the transcription pattern across the intraerythrocytic cell cycle, we performed Northern blots with total RNA of highly synchronized Plasmodium cultures. PCR-amplified etramp fragments (Table 1) were used to generate labeled probes. The low sequence homology among etramps ensured specificity of the probes.
Northern blot results are shown in Figure
2. As indicated with the dendrogram, the
most closely related etramps (2, 10.1, 11.1, 11.2, 12, and
14) showed similar, tightly regulated ring stage-specific
transcription, which is shut down before 18 hpi, corresponding to the
late ring stage (Figure 2, lanes 1-3). As apparent in lane 7, etramps2, 11.1, 11.2, and 12 are already transcribed in late
schizonts or very early ring stages (0-4 hpi). Transcription levels
occurred to be high, reflected in short exposure times (10-15 min).
etramps2, 14, and BLOB.1 are each encoded by two transcripts
of different sizes (~1.4 and 1.8 kb; ~1.5 and 2.1 kb, and ~2.0
and 2.3 kb, respectively) that partly overlap during different time
points. The large transcript sizes compared with the size of the coding
sequences observed for etramp2, 14.1, and BLOB.1 indicates
the presence of extensive untranslated regions. This feature, often
observed with P. falciparum mRNAs, was also seen with
etramp10.1 (~1.5 kb), etramp11.1 (~1.4 kb),
etramp11.2 (~2.4 kb), and etramp12 (~1 kb).
|
In contrast to the six most closely related etramps, etramp4 (~2.4 kb) was transcribed throughout the cycle, with peaks at the transition from ring stage to trophozoites and at the schizont stage. etrampBLOB.1 was transcribed from ring stage to mid-trophozoites, and etramp10.2 (~3.8 kb) and 10.3 (~2.4 kb) were mainly transcribed at the transition from ring to trophozoite stage. Transcriptional levels for etramp10.2 and 10.3 seemed to be much lower (8- and 16-h exposure time, respectively). etramp4, BLOB1, 10.2, and 10.3 define a much less consistent group but share a prominent increase in transcription at the transition from ring to trophozoite stage (Figure 2, lanes 3 and 4). This transcriptional activity coincides with the repression of the six ring-transcribed etramps.
We were unable to detect a signal with etramp13, 14.2, and BLOB.2, even after prolonged exposure. These sequences comprise a group of etramps most distinct from the others (Figure 2, dendrogram). Within this group, only etramp10.3 gave a signal on Northern blots containing RNA from asexual blood stages. Northern analysis was confirmed with independently isolated RNA covering the asexual cycle >5 time points (our unpublished data). Furthermore, Northern analysis with blots containing RNA of the P. falciparum strains HB3 and ITG2F6 showed transcripts of all etramps tested (etramps2, 4, 10.1, 11.2, 14.1, and BLOB.1; our unpublished data).
Characterization of anti-ETRAMP Sera
The C termini of five ETRAMPs were expressed as GST-fusion
proteins in E. coli (Figure 1C). We chose two ring
stage-transcribed ETRAMPs (ETRAMP2, aa 71-106 and ETRAMP10, aa
71-107) and three ETRAMPs that differed in transcription pattern
(ETRAMP4, aa 76-136; ETRAMP10.2, aa 78-355; and ETRAMP13, aa
84-185). To analyze antigenicity, all recombinant proteins were tested
on Western blots with a serum pool from semiimmune individuals from
Papua New Guinea. All recombinant fusion proteins but ETRAMP13 were
recognized as shown in Figure 3A. This
confirmed results from Northern blots in which no transcript of
ETRAMP13 could be detected, indicating that this protein is not (or at
very low levels) expressed in the human host. We therefore omitted
ETRAMP13 from further studies.
|
The four asexual stage ETRAMPs were recognized with a comparable strength as the merozoite surface protein-2 (Figure 3A, lane 2), and no signal was obtained with GST alone. Likewise, only the ETRAMP domain was recognized when the fusion protein was cleaved with PreScission protease (our unpublished data). Sera from infants of endemic areas or returning travelers with an acute P. falciparum infection readily recognized the fusion proteins, but no signal was obtained with sera from never-exposed individuals (our unpublished data). This demonstrates that ETRAMPs are expressed in vivo and that the recombinant protein is recognized by naturally occurring antibodies, and suggests a strong immunogenicity of these proteins.
We raised antibodies in mice against the four ETRAMP-GST fusion
proteins. Sera were tested on Western blots of total parasite protein
or RBC proteins separated by SDS-PAGE. None of the sera reacted with
RBC extracts (Figure 3B). Sera against ETRAMPs10.1, 2, and 4 recognized
single bands in the total parasite protein preparation (Figure 3B).
Bands were ~20% larger than the predicted sizes (including the
signal peptide) of 11.3 kDa for ETRAMP10.1, 11.5 kDa for ETRAMP2, and
14.9 kDa for ETRAMP4. As often observed with cationic proteins, bands
migrate slower than predicted. This is explained by nonuniform binding
of SDS to highly charged regions (Coppel et al., 1994
). It
is noteworthy that a signal was only obtained when methanol was omitted
from the Western transfer buffer. Due to the low protein concentration
of ring stages (these stages contain up to 30 times less protein than
mature parasites), P. falciparum cultures had to be enriched
for ring stages to obtain a signal with antisera against ETRAMP10.1 and 2.
Sera raised against ETRAMP10.2 reacted with two bands of 28 and 18 kDa
in total parasite extracts. Together, this accounts for 46 kDa, which
corresponds to the predicted size for ETRAMP10.2 (38.9 kDa), including
20% due to the high positive charge of this protein. ETRAMP10.2
contains a PEST sequence within the C terminus (aa 210-227, with a
PESTfind prediction score of 15). Such sequences are known to target
proteins for proteolysis (Rogers et al., 1986
; Rechsteiner
and Rogers, 1996
). Assuming a transmembrane location of ETRAMP10.2,
processing would result in the presence of one domain in the membrane
fraction, whereas the other domain would be found soluble. This was
confirmed on Western blots with the detergent-depleted fraction and the
membrane fraction (Figure 3, lanes s and m). Identical stage-specific
presence of both bands further indicated that they originated from the
same polypeptide (our unpublished data).
ETRAMPs Are Stage-specifically Expressed Membrane Proteins
Western analysis using fractions generated by Triton X-114 phase
separation of parasite proteins verified the predicted association of
ETRAMPs with the membrane fraction. Apart from the soluble part of
ETRAMP10.2 (Figure 3B), no ETRAMP could be detected in the Triton
X-114-insoluble or the Triton X-114-depleted fraction (Figure
4A).
|
We then used membrane extracts of synchronized parasites harvested during four consecutive time points of asexual development to analyze the expression pattern. The results shown in Figure 4B are consistent with the transcriptional analysis. Ring-transcribed ETRAMP10.1 and 2 were both only detected in extracts of ring stage parasites (Figure 4B, 2-22 hpi). ETRAMP4 was continuously found with a marked increase in schizonts and a moderate increase in ring stage parasites, which is in accordance with the transcription levels during the schizont stage. Levels of ETRAMP10.2 increased after the ring stage, immediately after the time point when an increase of transcription was observed in Northern blots. Thereafter, the protein persisted until the end of schizogony. Similar results with all four ETRAMPs were obtained with Western blots of total protein extracts (in HTPBS/0.5% Triton X-114) of synchronized parasites (our unpublished data).
Western analysis with rabbit anti EXP-1 sera and silver staining of SDS-PAGE gels confirmed equal loading of membrane extracts (Figure 4B; our unpublished data).
ETRAMPs Localize to Parasite Periphery
When IRBCs from asynchronous cultures were immobilized on concanavalin A-coated slides, dried, and fixed either with 1% formaldehyde or acetone, ETRAMP antisera gave a positive IFA signal. No signal was obtained when slides were fixed with methanol or ethanol.
Both sera against the ring stage expressed ETRAMP2 and 10.1 labeled a
complete or partial ring (our unpublished data; Figure 5E with cells that were not dried). IFAs
with synchronized parasites revealed that ETRAMP2 and 10.1 labeled all
ring stage parasites, but no fluorescence was found in later stage
parasites (our unpublished data). This is accordance with the
results obtained in Western blots.
|
ETRAMP4 and 10.2 were also localized to the periphery of the parasite (shown for ETRAMP4 in Figure 5A), with much weaker staining of ETRAMP10.2. Usually, the distribution of both ETRAMPs around the cell was not uniform as seen in Figure 5A showing a schizont (top two panels) and a trophozoite stage parasite (bottom panels). Most parasites had either an additional single patch of fluorescence (Figure 5A, thick arrow), intermittent regions of stronger fluorescence (Figure 5A, small arrows), or blebbing extensions from the parasite (Figure 5B). Costaining with Cy3-labeled anti-aldolase showed that the parasite cytoplasm is encircled by the ETRAMP signal (Figure 5C). In contrast to the ring stage-expressed ETRAMPs, we observed fluorescence only in later stage parasites (our unpublished data). This is in contrast to results from Western and Northern blots obtained for ETRAMP4 and may indicate that the protein is masked in ring stages. This is further supported by the almost complete loss of signal on Western blots by using stage-specific protein extracts from parasites that were cross-linked with 1% formaldehyde before protein extraction (Figure 4C). No labeling was observed with segmented schizonts.
To exclude that the similar fluorescence pattern was due to cross-reactivity between ETRAMPs, we preincubated sera against ETRAMP with an excess of each expressed ETRAMP. Immunofluorescence was only abolished with the corresponding GST-fusion protein, but neither with any of the other ETRAMP-fusion proteins or with GST alone (our unpublished data). No fluorescence was observed with sera against GST (our unpublished data).
ETRAMPs Are Located in PVM
Peripheral labeling obtained with all antisera suggested a
localization of ETRAMPs in the PPM or the PVM. But the close
association of these membranes does not allow assignment of the signal
to one of these compartments. To determine the exact location of ETRAMPs, we applied the selective permeabilization procedure for Western analysis (Ansorge et al., 1997
) to IFAs. A schematic
representation of the procedure is shown in Figure 5D. IRBCs were
either treated with saponin, which permeabilizes the RBC membrane and
the PVM but not the PPM (Figure 5D, ii), or with SLO, which
permeabilizes the RBC membrane only but leaves intact the PVM and the
PPM (Figure 5D, iii). Anti-ETRAMP sera were added to IRBCs treated with
one of these two agents, and the cells were analyzed by
immunofluorescence. Depending on the location of ETRAMPs, a
fluorescence signal is only observed if the permeabilizing agent
created access to the antigen. In all experiments, a rabbit serum
specific for parasite aldolase was added together with the mouse
anti-ETRAMP serum to confirm that antibodies had no access to the
parasite cytosol after selective permeabilization. As a positive
control, IRBCs were dried or treated with Triton X-100 to permeabilize
all membranes.
In mildly or unfixed cells, permeabilized with saponin or SLO,
fluorescence was only observed with sera against the ring expressed ETRAMP10.1 and 2, whereas aldolase staining was only visible in Triton
X-100-permeabilized cells (Table 2 and
Figure 5, E and F). We were not able to detect ETRAMPs after treatment
of cells with Triton X-100, but dried and fixed cells showed a signal
with all sera, indicating the presence of all antigens (Table 2). Because sera were raised against the C-terminal domain of ETRAMPs, the
signal with saponin-permeabilized IRBCs demonstrated that the C termini
of both ring-expressed ETRAMPs were located outside of the parasite
PPM. Furthermore, immunofluorescence with SLO-treated IRBCs showed that
ETRAMP10.1 and 2 could only be located in the PVM, with the C terminus
facing the RBC cytoplasm.
|
To obtain a signal with sera against ETRAMP4 and 10.2, the formaldehyde concentration had to be raised to 0.5% (Table 2), resulting in some loss of cell integrity. This was evident in a low proportion of nonpermeabilized cells with an ETRAMP signal (Table 2) and in permeabilized cells with a faint staining of aldolase. Therefore, we could not completely exclude that ETRAMP4 and 10.2 are located in the PPM, although the extensions from the parasite periphery suggest PVM location (Figure 5B).
To corroborate further localization of ETRAMP4 in the PVM, we performed
Western blots with proteins from saponin-treated and subsequently
trypsinized cells. In the proposed classical vesicular transport
pathway inside plasmodial cells (Albano et al., 1999b
), a
type I integral PPM protein would face the parasite cytoplasm with the
C terminus. After permeabilization and trypsination, we would expect
ETRAMP4 to be truncated to the TM and the C terminus. But no truncated
protein was detected on Western blots and the ETRAMP4 signal was lost
completely (Figure 5G). This is in accordance with a localization of
ETRAMP4 in the PVM and was also shown for ETRAMP10.1. In contrast,
PfGAPDH was still detected with a monoclonal antibody in trypsinized
and control fractions of the same extracts, demonstrating that trypsin
was unable to enter the cytoplasm of the parasite.
By immunoelectron microscopy, it was observed that infected cells
containing young trophozoites and stained for ETRAMP2 showed labeling
of the outer aspect of the PVM (Figure 6,
A-C). The red cell membrane, Maurer's clefts and PPM were unlabeled.
It was also noted that certain extensions of the PVM and tubovesicular blebs were also strongly labeled (Figure 6, D and E). In samples stained for ETRAMP4, the level of staining was lower but a similar pattern was observed with labeling of the PVM of certain cells containing more mature multinucleate trophozoites (Figure 6F).
|
ETRAMP4 and 10.2 Colocalize with Markers of Parasitophorous Vacuole (PV) and PVM
We performed colocalization studies with dried and acetone-fixed cells by using rabbit antisera against EXP-1, a PVM membrane protein, and SERP, a soluble protein found in the PV of late stage parasites
Colocalization by confocal microscopy with serum against SERP revealed
only limited overlap in stage specificity with ETRAMP4 and 10.2. These
ETRAMPs occurred earlier in the cycle than SERP and were not detectable
in the late schizont. However, when both proteins were present, cells
clearly showed similar peripheral labeling for both antigens, although
distribution around the cell differed slightly (shown for ETRAMP4 in
Figure 7A). The expanded peripheral
ETRAMP4 location (arrow, Figure 7A) might be due to an artificial
detachment of the PVM due to drying and fixing.
|
Analysis of ETRAMP4 and EXP-1 colocalization by using fluorescent
microscopy showed overlapping staining around the periphery of the
cell. EXP-1 was found occasionally as small fluorescent dots inside the
RBC cytosol, often close to the PVM, which might reflect the known
association with vesicular structures in the RBC cytoplasm (Simmons
et al., 1987
; Kara et al., 1988a
,b
). ETRAMP4 colocalized also to these dots that occurred either disconnected from
the PVM (Figure 7B, arrows) or connected to the PVM (Figure 7C,
arrows). When the focus was adjusted to the dots, the parasite body was
slightly out of focus and peripheral staining was less prominent.
Occasionally, there were also dots or extensions from the PVM showing
only one of the two antigens (our unpublished data). These
results further corroborate a PVM location of ETRAMP4.
Ring Stage-expressed ETRAMPs Define Discrete Domains in PVM
Colocalization of ring-expressed ETRAMPs (2 and 10.2) and EXP-1
was analyzed with saponin-permeabilized IRBCs. For both EXP-1 and
ETRAMPs, fluorescence around the cell seemed concentrated at discrete
sites. Together, the two antigens gave a ring-formed distribution
around the parasite but did clearly not colocalize (shown for
ETRAMP10.1 in Figure 7D). A similar distribution was also seen with
ring stage-infected cells showing a bead on a string fluorescence, a
pattern we observed frequently in unfixed cells, and that has been
described for proteins in the PV detected in unfixed ring stages
(Waller et al., 2000
; Wickham et al., 2001
). Again, beads showed either green (ETRAMP) or red (EXP-1) labeling (shown for ETRAMP2 in Figure 7E) with occasional overlaps (Figure 7, D
and E, arrows). Similar results were obtained with both fixed and
unfixed IRBCs.
To analyze the three-dimensional distribution of ring stage-specific
ETRAMPs and EXP-1, dried and formaldehyde-fixed IRBCs were analyzed by
confocal microscopy. Focus was adjusted to the center of a parasite,
and optical planes 0, +0.8, and
0.8 µm were recorded for EXP-1 and
ETRAMP10.1. As shown in Figure 7F, the two signals varied considerably
in their distribution, e.g., EXP-1 was only present in the top and
central optical section, and ETRAMP10.1 only in the central and lower
plane. Optical sections ±1.6 µm showed no signal, demonstrating that
the observed staining derived from a single cell. Analysis of several
cells showed similar results, with optical planes often showing only
one signal or both with clear spatial separation. These results clearly
indicate spatial separation of ETRAMPs and EXP-1 in different domains
of the PVM.
| |
DISCUSSION |
|---|
|
|
|---|
The P. falciparum ring stage takes up the first half of
asexual intraerythrocytic development, and our understanding of the molecular events during this stage is very limited. Herein, we have
described and characterized a new P. falciparum gene family called etramp, coding for highly charged, small membrane
proteins. Using etramps isolated from a ring stage-specific
cDNA library (Spielmann and Beck, 2000
), we identified a total of 13 etramps from the P. falciparum genome. Six
members belonged to a coherent group expressed exclusively in the ring
stage, whereas other members showed a different developmental
regulation. Some ETRAMPs were not transcribed at all in asexual blood
stage parasites. One of these, ETRAMPs (ETRAMP13), shows 31% aa
identity to a P. yoelii protein (Py22) with typical features
of an ETRAMP. Py22 is transcribed in salivary gland sporozoites
(Matuschewski et al., 2002
), indicating that expression of
the ETRAMP protein family is not restricted to blood stages. ETRAMP13
was previously published as OrfP and detected by reverse
transcription-PCR but not by Northern analysis of asexual blood stage
RNA (Sallicandro et al., 2000
). We also failed to detect the
corresponding mRNA on Northern blots, and we did not find natural
antibodies against the recombinant GST-fusion protein. Because we have
only analyzed asexual blood stages, ETRAMP13 might be expressed in
other life cycle stages.
We used colocalization and selective permeabilization IFAs to determine
the location of four ETRAMPs in IRBCs. Whereas both ring-expressed
ETRAMPs could be unequivocally localized to the PVM, ETRAMP4 and 10.2 were only detectable in selectively permeabilized cells fixed with
0.5% formaldehyde. The peripheral staining with antisera against these
ETRAMPs suggested that they were either located in the PPM, or fixing
was required to detect them in the PVM. There are several lines of
evidence for the latter possibility: 1) with 0.5% formaldehyde,
aldolase signal was very faint, indicating that access to the cytosol
of the parasite was limited, but anti-ETRAMP signal was intense.
Moreover, in unfixed or mildly fixed cells, the antiserum against the C
terminus of EXP-1 was only reactive with the PVM of ring stage
parasites, whereas all parasites were recognized with 0.5%
formaldehyde (our unpublished data), pointing to a general
stage-specific effect. 2) Western analysis with extracts obtained from
saponin-treated and trypsinized IRBCs indicated PVM localization. 3)
Extensions from the cell periphery, including dots in the RBC
cytoplasm, were decorated by the anti-ETRAMP sera, and colocalized with
the PVM protein EXP-1. Such structures have previously been shown to
contain EXP-1 and were attributed to vesicles in the RBC cytoplasm and
the TVN originating from the PVM (Simmons et al.,
1987
; Kara et al., 1988a
,b
). Further corroborating these
findings, immunoelectron microscopy of saponin-permeabilized IRBCs with
sera against ETRAMP2 and 4 showed specific staining of the PVM facing
the RBC cytosol as well as PVM extensions and proximate vesicles.
Together, these results strongly indicate PVM localization of all four
ETRAMPs tested and suggest a similar localization for all other ETRAMPs
expressed during the asexual blood stage. Furthermore, the SLO and
immunoelectron microscopy experiments showed that ETRAMP C termini face
the RBC cytoplasm, whereas the N terminus protrudes into the PV. This
orientation is similar to that of EXP-1 (Ansorge et al.,
1997
), the only well characterized P. falciparum integral
PVM protein.
In the related apicomplexan Toxoplasma gondii, the rhoptry
proteins ROP2, 3, 4, and 7 are inserted into the PVM (Beckers et al., 1994
) in a process concomitant with host cell invasion and PVM formation. In P. falciparum, proteins derived from
merozoite apical organelles were also found to be associated with the
PVM after invasion (Bushell et al., 1988
; Sam-Yellowe
et al., 1988
; Trager et al., 1992
) but in
contrast to T. gondii, these structures seem to be lost
after invasion. We cannot exclude that some ETRAMPs are already
inserted into the PVM upon invasion. However, different ETRAMPs are
synthesized at various stages of the asexual blood cycle, demonstrating
transport to the PVM throughout intraerythrocytic development.
Furthermore, we did not detect ETRAMPs in late schizonts, which would
be a prerequisite for PVM insertion upon invasion. Therefore, ETRAMP
transport is comparable with secretion from the dense granules in
T. gondii, which occurs after invasion (Carruthers and
Sibley, 1997
). The orientation of ETRAMPs in the PVM supports a
continuous vesicle fusion-budding protein transport to the PVM originally proposed on the basis of EXP-1 orientation (Günther et al., 1991
; Ansorge et al., 1997
; Lingelbach
and Joiner, 1998
). This contrasts the T. gondii dense
granule protein GRA5, which is secreted as a soluble protein and is
subsequently inserted into the PVM as a transmembrane protein in the
opposite orientation (Lecordier et al., 1999
).
It seems that in P. falciparum, the default secretory route
for soluble proteins targets them to the PV (Waller et al.,
2000
; Wickham et al., 2001
) or possibly into the RBC cytosol
(Burghaus and Lingelbach, 2001
). It is not known whether integral
membrane proteins are also exported by default and whether there are
specific PVM retention motifs. Targeting signals are often present in
the C-terminal cytoplasmic domains (Urbe et al., 1997
).
However, no obvious common aa sequence element was found in ETRAMP C
termini. Either the targeting information lies in the more conserved N terminus, is very variable, or no specific signal is required for
transport and retention in the PVM. Posttranslational modifications could also mediate targeting. EXP-1 was shown to be myristilated (Kara
et al., 1988a
). We cannot exclude that the observed larger size of ETRAMPs on Western blots of parasite extracts is due to such modifications.
We showed that in the ring stage, the PVM contains subdomains in terms
of protein composition. The cationic ring-expressed ETRAMPs define
discrete regions compared with the anionic PVM protein EXP-1. This
implies that two functionally distinct domains exist in the PVM.
Nonuniform distribution of EXP-1 around the cell has already been
observed (Behari and Haldar, 1994
). But in contrast to EXP-1, the
ETRAMP composition of the PVM changes with development. The
ring-expressed ETRAMPs disappear and are replaced by other ETRAMPs at
the transition from ring to trophozoite stage. There is also a peak in
transcription for ETRAMP4 and B1 during this transition stage,
suggesting increased synthesis of these proteins. Therefore, the host
cell-parasite interface changes its properties concomitant with
morphological changes, a first peak of increased protein synthesis (de
Rojas and Wasserman, 1985
), appearance of parasite-induced host cell
modifications, and subsequent rapid parasite growth. The early
appearance of parasite proteins at the parasite-host cell interface is
in accordance with the need to create a connection to the host cell to
acquire nutrients and to establish protein transport into the RBCs. The
ring-expressed ETRAMPs define this stage and are part of a set of early
transcribed genes lacking homologies to known proteins (Spielmann and
Beck, 2000
). This is in accordance with a unique nature of this process in cell biology. We propose that the loss of ring-expressed ETRAMPs defines a switch in development seen in the morphological transition from ring to trophozoite stage. This makes ETRAMPs excellent markers for this stage both at the RNA and the protein level.
Highly charged molecules such as ETRAMPs could interact with structural proteins to fix the PVM in the RBCs or could interact with soluble proteins in the parasite cytoplasm to act as carriers out of the parasite. However, we were unsuccessful to detect interaction partners (from parasite and RBC extracts) with the recombinant ETRAMP C termini fused to GST by using GST pull-down and Far Western techniques (our unpublished data).
ETRAMPs could also interact with each other, requiring a membrane
environment and the predicted coiled coil domains on both sides of the
TM. Such multimers could form a channel that is responsible for the
molecular sieve properties of the PVM (Desai et al., 1993
; Desai and Rosenberg, 1997
) or might be involved in protein transport through the PVM (Ansorge et al., 1996
). However, it has to
be noted that coiled coil predictions of lysine-rich sequences have to
be interpreted with care (Berger et al., 1995
).
There are striking analogies between ETRAMPs and integral PVM proteins
found in other intracellular pathogens, indicating a common scheme to
equip this compartment. Similar to ETRAMPs, the T. gondii
rhoptry proteins ROP2, 4, 7, and 8 have a pI > 9; share sequence
homology among each other; contain a TM; are found in the PVM early
after invasion; and show punctuate, nonuniform localization around the
cell periphery (Beckers et al., 1994
). Chlamydia
spp. modify their PVM by insertion of Inc proteins. This family
contains many charged proteins and shares a characteristic hydrophobic
domain of >40 aa, but otherwise exhibits no sequence similarity. Inc
proteins are small proteins expressed early after infection
(Scidmore-Carlson et al., 1999
), and some are unevenly distributed around the cell (Bannantine et al., 1998
;
Scidmore-Carlson et al., 1999
). Neither ETRAMPs nor Incs nor
ROP proteins show sequence homology to known proteins. To date, little
is known about the function of PVM-located proteins. ROP2 was recently shown to mediate association of host cell organelles to the T. gondii PVM (Sinai and Joiner, 2001
), and IncA seems to be involved in fusion of different Chlamydia inclusions (Hackstadt
et al., 1999
). Although such functions are not required for
Plasmodium blood stages, the ability of these proteins to
mediate interaction or fusion with membranes might be relevant for
ETRAMPs and a common property of PVM proteins. The domain responsible
for ROP2 insertion into lipid bilayers is highly positively charged, a
feature also typical for ETRAMPs. High positive charge is a
characteristic of proteins capable to directly traverse membranes
(Schwarze and Dowdy, 2000
) and of peptides capable to disrupt lipid
bilayers (Bechinger, 1997
). If ETRAMPs had membrane
interacting/penetrating capabilities, they could be required for the
proposed junction between the TVN and the RBC membrane to acquire
nutrients (Lauer et al., 1997
), to obtain lipids from the
RBC membrane, for vesicular transport processes at the PVM, or to
anchor the PVM to the RBC membrane. Different membrane interaction
tasks would explain the presence of a number of related proteins and
the need for different proteins during different life cycle stages.
Furthermore, the biophysical properties required for such a function,
as binding negative lipid head groups or insertion into lipid bilayers,
could explain the technical difficulties encountered to detect ETRAMPs when methanol or Triton X-100 was used.
We were unable to demonstrate any sequence difference between
etramps of different strains, and all parasites expressed
all ETRAMPs they were analyzed for. The presence of etramp
transcripts in strains other than 3D7 indicates that this gene family
is expressed in all P. falciparum strains. Furthermore,
ETRAMPs were readily recognized by sera of malaria patients, indicating
expression in vivo. The strong antigenicity of ETRAMPs is notable in
the light of the protective immune response against a PVM located antigen of liver stages (Charoenvit et al., 1999
).
The presence of ETRAMP homologs in other Plasmodium species indicates that this family is involved in processes common to all Plasmodia. Intracellular pathogens residing in a PVM have to maintain this barrier and must be equipped to allow controlled cross talk and to modify it according to the needs of each the life cycle stage. ETRAMP composition in the P. falciparum PVM is subjected to a dynamic change concomitant with parasite development. Furthermore, ring expressed ETRAMPs define subdomains in the PVM. This indicates spatial- and stage-dependent functional heterogeneity of this compartment. Therefore, we believe that ETRAMPs are important mediators of the Plasmodium-host cell interaction and will reveal significant insight into the biology of Plasmodium and the properties of host-parasite interfaces of intracellular pathogens in general.
| |
ACKNOWLEDGMENTS |
|---|
We thank Drs. T. Voss, K. Lingelbach, and J. Burckhardt for critically reading the manuscript and comments. We are grateful to Drs. K. Lingelbach and S. Baumeister for antisera against aldolase, EXP-1, and SERP and to Dr. C. Daubenberger for antibodies to GAPDH. We also thank Dr. H. Reichert for providing access to the confocal microscope and S. Sprecher and L. Kammermeier for expert help with this instrument. We are grateful for Dr. R. Brun and S. Scheurer of the protozoology group for providing culture facilities and consumables. We also thank I. Endriss and K. Gysin for doing the mouse work. We thank the scientists and funding agencies comprising the international Malaria Genome Project for making sequence data from the genome of P. falciparum (3D7) public before publication of the completed sequence. D.J.P.F. was supported by an equipment grant of the Wellcome Trust. The Sanger Center provided sequence for chromosomes 1, 3-9, and 13, with financial support from the Wellcome Trust. A consortium composed of The Institute for Genome Research, along with the Naval Medical Research Center, sequenced chromosomes 2, 10, 11, and 14, with support from National Institute of Allergy and Infectious Diseases/National Institutes of Health, the Burroughs Wellcome Fund, and the Department of Defense. The Stanford Genome Technology Center sequenced chromosome 12, with support from the Burroughs Wellcome Fund. The Plasmodium Genome Database is a collaborative effort of investigators at the University of Pennsylvania and Monash University, supported by the Burroughs Wellcome Fund.
| |
FOOTNOTES |
|---|
Present address: Queensland Institute of Medical
Research, Brisbane, QLD 4006, Australia.
§ Corresponding author. E-mail address: hans-peter.beck{at}unibas.ch.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02-04-0240. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02-04-0240.
| |
ABBREVIATIONS |
|---|
Abbreviations used: aa, amino acid(s); IRBC, infected red blood cell; hpi, hours postinvasion; PPM, parasite plasma membrane; PV, parasitophorous vacuole; PVM, PV membrane; RBC, red blood cell; TVN, tubovesicular network.
| |
REFERENCES |
|---|
|
|
|---|
interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
Infect. Immun.
67, 5604-5614
-hematin supports heme polymerization in the absence of protein.
Nature
374, 269-271[CrossRef][Medline].This article has been cited by other articles:
![]() |
L. Hinds, J. L. Green, E. Knuepfer, M. Grainger, and A. A. Holder Novel Putative Glycosylphosphatidylinositol-Anchored Micronemal Antigen of Plasmodium falciparum That Binds to Erythrocytes Eukaryot. Cell, December 1, 2009; 8(12): 1869 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haase, A. Cabrera, C. Langer, M. Treeck, N. Struck, S. Herrmann, P. W. Jansen, I. Bruchhaus, A. Bachmann, S. Dias, et al. Characterization of a Conserved Rhoptry-Associated Leucine Zipper-Like Protein in the Malaria Parasite Plasmodium falciparum Infect. Immun., March 1, 2008; 76(3): 879 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Spielmann, P. L. Hawthorne, M. W.A. Dixon, M. Hannemann, K. Klotz, D. J. Kemp, N. Klonis, L. Tilley, K. R. Trenholme, and D. L. Gardiner A Cluster of Ring Stage-specific Genes Linked to a Locus Implicated in Cytoadherence in Plasmodium falciparum Codes for PEXEL-negative and PEXEL-positive Proteins Exported into the Host Cell Mol. Biol. Cell, August 1, 2006; 17(8): 3613 - 3624. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spycher, M. Rug, N. Klonis, D. J. P. Ferguson, A. F. Cowman, H.-P. Beck, and L. Tilley Genesis of and Trafficking to the Maurer's Clefts of Plasmodium falciparum-Infected Erythrocytes Mol. Cell. Biol., June 1, 2006; 26(11): 4074 - 4085. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Drew, P. R. Sanders, and B. S. Crabb Plasmodium falciparum Merozoite Surface Protein 8 Is a Ring-Stage Membrane Protein That Localizes to the Parasitophorous Vacuole of Infected Erythrocytes Infect. Immun., July 1, 2005; 73(7): 3912 - 3922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. Mueller, N. Camargo, K. Kaiser, C. Andorfer, U. Frevert, K. Matuschewski, and S. H. I. Kappe Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface PNAS, February 22, 2005; 102(8): 3022 - 3027. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rug, M. E. Wickham, M. Foley, A. F. Cowman, and L. Tilley Correct Promoter Control Is Needed for Trafficking of the Ring-Infected Erythrocyte Surface Antigen to the Host Cytosol in Transfected Malaria Parasites Infect. Immun., October 1, 2004; 72(10): 6095 - 6105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spycher, N. Klonis, T. Spielmann, E. Kump, S. Steiger, L. Tilley, and H.-P. Beck MAHRP-1, a Novel Plasmodium falciparum Histidine-rich Protein, Binds Ferriprotoporphyrin IX and Localizes to the Maurer's Clefts J. Biol. Chem., September 12, 2003; 278(37): 35373 - 35383. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||